PYXS · Insider trading · 13F holders · Congress trades
Pyxis Oncology, Inc. (PYXS)
Who is buying and selling PYXS: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 7
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
PYXS at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 PYXS insider filed 1 open-market purchase worth $0.00 on SEC Form 4.
- 7 13F filers hold PYXS among their 50 largest positions, worth $71.0M combined. The biggest bets by portfolio weight are GordonMD Global Investments LP (14.6%), Pfizer Inc (11.4%) and Laurion Capital Management LP (1.1%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
- No member of Congress has disclosed a trade in PYXS.
- PYXS last closed at $1.89 on Oct 29, 2026.
PYXS insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 PYXS insider filed 1 open-market purchase worth $0.00 on SEC Form 4.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | GordonMD Global Investments LP | 10% Owner | Buy | 5,517,000 | $0.00 | $0.00 | SEC |
Who owns PYXS? Hedge funds and superinvestors
7 13F filers hold PYXS among their 50 largest positions, worth $71.0M combined. The biggest bets by portfolio weight are GordonMD Global Investments LP (14.6%), Pfizer Inc (11.4%) and Laurion Capital Management LP (1.1%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| GordonMD Global Investments LPHedge fund | 14.6% | $30.2M | 10,024,909 | +143.2% shares | Q2 2026 |
| Pfizer IncCorporation | 11.4% | $19.5M | 7,032,770 | +0.0% shares | Q2 2026 |
| Laurion Capital Management LPHedge fund | 1.1% | $14.8M | 4,900,888 | -1.9% shares | Q2 2026 |
| Atle Fund Management ABAsset manager | 0.8% | $2.9M | 966,459 | +390.5% shares | Q2 2026 |
| Palo Alto Investors LPHedge fund | 0.4% | $2.6M | 864,277 | -14.5% shares | Q2 2026 |
| Decheng Capital LLCHedge fund | 0.1% | $984K | 326,810 | +0.0% shares | Q2 2026 |
| University of ChicagoEndowment & foundation | 0.0% | $147K | 48,731 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 7). Screen PYXS in the grand portfolio →
PYXS stock trades by members of Congress
No member of Congress has disclosed a trade in PYXS.
PYXS questions and answers
Are insiders buying PYXS stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 PYXS insider filed 1 open-market purchase worth $0.00 on SEC Form 4.
Which hedge funds own PYXS?
7 13F filers hold PYXS among their 50 largest positions, worth $71.0M combined. The biggest bets by portfolio weight are GordonMD Global Investments LP (14.6%), Pfizer Inc (11.4%) and Laurion Capital Management LP (1.1%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
Has Congress traded PYXS?
No member of Congress has disclosed a trade in PYXS.
Who is the largest holder of PYXS?
Among 13F filers, GordonMD Global Investments LP reports the largest PYXS position, $30.2M (10,024,909 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is GordonMD Global Investments LP's: 14.6% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.